Are the UTHR share gifts by Martine Rothblatt direct or indirect holdings?

All reported UNITED THERAPEUTICS Corp share gifts involve indirect holdings. The shares are held by family trusts or a spouse, with ownership coded as indirect and described as “by Trust” or “by Spouse.”

United Therapeutics (UTHR) CEO makes 11,069-share family trust gift

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

UNITED THERAPEUTICS Corp Chairperson & CEO Martine Rothblatt reported indirect gifts of company stock held through family trusts. The filing shows two bona fide gifts of Common Stock totaling 11,069 shares, made at a price of $0.00 per share.

After these gifts, one reporting trust holds 8,902 shares of United Therapeutics Common Stock and another trust holds 249,108 shares, both reported as indirect ownership. Additional indirect holdings disclosed include 45,596 shares and 324,443 shares held by family trusts, and 166 shares held by a spouse. These are non-market, gratuitous transfers and not open-market sales.

Insider Trade Summary

11,069 shares gifted

Mixed 5 txns

Insider ROTHBLATT MARTINE A

Role Chairperson & CEO

Type	Security	Shares	Price	Value
Gift	Common Stock	9,009	$0.00	--
Gift	Common Stock	2,060	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 249,108 shares (Indirect, by Trust)

Footnotes (1)

Bona fide gift of shares Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

Key Figures

Total shares gifted: 11,069 shares First gift amount: 2,060 shares Second gift amount: 9,009 shares +5 more

8 metrics

Total shares gifted 11,069 shares Sum of two bona fide gifts of Common Stock

First gift amount 2,060 shares Common Stock bona fide gift at $0.00 per share

Second gift amount 9,009 shares Common Stock bona fide gift at $0.00 per share

Trust holding after first gift 8,902 shares Total shares following 2,060-share gift, indirect by trust

Trust holding after second gift 249,108 shares Total shares following 9,009-share gift, indirect by trust

Additional trust holding 45,596 shares Indirect ownership by trust, total shares following transaction

Additional trust holding 324,443 shares Indirect ownership by trust, total shares following transaction

Spouse-held shares 166 shares Indirect ownership described as by spouse

Key Terms

bona fide gift, indirect ownership, family trusts, investment power, +1 more

5 terms

bona fide gift financial

"transaction_code_description: "Bona fide gift" for two Common Stock entries"

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

indirect ownership financial

"ownership_type marked as "indirect" and ownership_code "I" for all entries"

family trusts financial

"Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke."

investment power financial

"Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries."

Form 4 regulatory

"INSIDER FILING DATA (Form 4) for UNITED THERAPEUTICS Corp"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

05/26/2026 - 04:44 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROTHBLATT MARTINE A

(Last)

(First)

(Middle)

C/O UNITED THERAPEUTICS CORPORATION

1000 SPRING STREET

(Street)

SILVER SPRING

MARYLAND

20910

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITED THERAPEUTICS Corp [ UTHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chairperson & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/26/2026		G		9,009	D	⁽¹⁾	249,108	I	by Trust⁽²⁾
Common Stock	05/26/2026		G		2,060	D	⁽¹⁾	8,902	I	By Trust⁽³⁾
Common Stock								166	I	by Spouse
Common Stock								324,443	I	by Trust⁽⁴⁾
Common Stock								45,596	I	by Trust⁽⁵⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Bona fide gift of shares

2. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

3. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

4. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

5. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

Remarks:

	/s/ John S. Hess, Jr. under Power of Attorney	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did UTHR CEO Martine Rothblatt report?

Martine Rothblatt reported two bona fide gifts of UNITED THERAPEUTICS Corp Common Stock totaling 11,069 shares. These were indirect transfers from family trusts at $0.00 per share, not open-market sales or purchases.

How many UTHR shares were gifted in this Form 4 filing?

The Form 4 reports gifts of 2,060 and 9,009 UNITED THERAPEUTICS Corp shares, totaling 11,069 shares. Both transactions are coded as bona fide gifts and were executed at a price of $0.00 per share.

How many UTHR shares remain in the gifting trusts after the transactions?

After the gifts, one family trust holds 8,902 UNITED THERAPEUTICS Corp shares and another holds 249,108 shares. These post-transaction balances are disclosed as total shares following each gift transaction.

Does the UTHR Form 4 show any open-market buys or sells by the CEO?

The Form 4 does not show any open-market purchases or sales. It reports two bona fide gifts of UNITED THERAPEUTICS Corp shares and several holding entries, all classified as indirect ownership positions.